CAMRESE LO
Live / Registered — Registered and renewed (as of 19 Mar 2024)
What this means for you
Registered since 15 Oct 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Oct 2023).
Record
- Serial number
- 85855235
- Registration number
- 4417937
- Mark type
- Stylized text
- Filed
- 20 Feb 2013
- Published for opposition
- 30 Jul 2013
- Registered
- 15 Oct 2013
- Next maintenance due
- 15 Oct 2023
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, oral contraceptives, hormone replacement therapies and hormonal agents for treating disorders and conditions related to women's health
Owner
- Teva Pharmaceuticals USA, Inc., Parsippany, NJ, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
Prior registrations
Prosecution history
- 09 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 19 Mar 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 19 Mar 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Oct 2023 — TEAS SECTION 8 & 9 RECEIVED
- 15 Oct 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 28 Jan 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 28 Jan 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Jan 2020 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 22 Nov 2019 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15